ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Activation of APE1 modulates Nrf2 protected against acute liver injury by inhibit hepatocyte ferroptosis and promote hepatocyte autophagy

Diao, Jianxin; Fan, Huijie; Zhang, Jia; Fu, Xiuqiong; Liao, Rongxin; Zhao, Peng; Huang, Wei; Huang, Shiying; Liao, Huajun; Yu, Jieying; Pan, Dongmei; Wang, Ming*; Xiao, Wei*; Wen, Xiaomin*广东药学院; 南方医科大学
International Immunopharmacology2024-2-15DOI: 10.1016/j.intimp.2024.111529
6阅读
引用收藏
分享

摘要

Background: Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) plays a crucial role in DNA base excision repair, cell apoptosis, cell signaling, and the regulation of transcription factors through redox modulation and the control of reactive oxygen species (ROS). However, the connection between APE1 and acute liver injury (ALI) remains enigmatic. This study aims to unravel the molecular mechanisms underlying ALI and shed light on the role of APE1 in this context. Method: We induced acute liver injury (ALI) in mice by lipopolysaccharide/D-galactosamine (LPS/GalN) and intervened with the APE1 inhibitor E3330. We examined the expression of APE1 in ALI mice and ALI patient tissues after E3330 intervention, Additionally, we measured hepatic oxidative stress, ferroptosis, and autophagy marker proteins and genes. In establishing an AML-12 liver cell injury model, we utilized the Nrf2 activator tertbutylhydroquinone (TBHQ) as an intervention and examined APE1, Nrf2, ferroptosis-related proteins, and autophagy marker proteins and mRNA. Results: Both ALI patients and ALI mice exhibited reduced APE1 expression levels. After E3330 intervention, there was a significant exacerbation of liver injury, oxidative stress, and a reduction in the expression of proteins, including GPX4, X-CT, ATG3, ATG5, and LC3 (LC3I/II). Consistent results were also observed in AML-12 cells. With TBHQ intervention, Nrf2 expression increased, along with the expression of proteins associated with iron death and autophagy. Mechanistically, APE1 activation regulates Nrf2 to inhibit ferroptosis and promote autophagy in hepatocytes. Conclusion: The data suggest that APE1 is a pivotal player in ALI, closely linked to its regulation of Nrf2. Strategies involving APE1 activation to modulate Nrf2, thereby inhibiting hepatocyte ferroptosis and promoting autophagy, may represent innovative therapeutic approaches for ALI. Additionally, tert-butylhydroquinone (TBHQ) holds significant promise in the treatment of acute liver injury.

学科与关键词

关键词
Acute liver injuryApurinic/apyrimidinic endonuclease 1/redoxeffector factor 1FerroptosisAutophagyNuclear erythroid factor 2 like 2
相关
加载中…
  • Kaempferol prevents acetaminophen-induced liver injury by suppressing hepatocyte ferroptosis via Nrf2 pathway activation
    Li, Huiyi; Weng, Qiqing; Gong, Shuai; Zhang, Weixian; Wang, Jiaqi; Huang, Yuqiao; Li, Yuanjun; Guo, Jiao; Lan, Tian*Food & Function, 2023, 14(4): 1884-1896.被引 14
  • Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure Through Inhibiting GSK3β-Nrf2-Mediated Hepatocyte Apoptosis and Ferroptosis
    Huang, Sha; Wang, Yuhua; Xie, Shunwen; Lai, Yuqi; Mo, Chan; Zeng, Ting; Kuang, Shanshan; Deng, Guanghui; Zhou, Chuying; Chen, Yuyao; Huang, Shaohui; Gao, Lei*; Lv, Zhiping*Cellular and Molecular Gastroenterology and Hepatology, 2022, 13(6): 1649-1672.被引 23
  • HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression
    Liu, Guo-Zhen; Xu, Xu-Wen; Tao, Shu-Hui; Gao, Ming-Jian; Hou, Zhou-Hua*Journal of Biomedical Science, 2021, 28(1): 67.被引 41
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2024-02-15
卷期
第 128 卷
页码
111529
DOI
10.1016/j.intimp.2024.111529
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82074257, 82174323, 82004103]; Natural Science Foundation of Guangdong Province [2019A1515011034, 2023A1515011200, 2022A1515011668]; Project of Administration of Traditional Chinese Medicine of Guangdong Province [20232068]; Scientific Research Fund of People's Hospital of Yangjiang [G2020001]

作者

  • D

    Diao, Jianxin (第一作者)

    southern med univ

  • F

    Fan, Huijie

    southern med univ

查看全部 14 位作者收起作者
  • Z

    Zhang, Jia

    southern med univ

  • F

    Fu, Xiuqiong

    hong kong baptist univ

  • L

    Liao, Rongxin

    southern med univ

  • Z

    Zhao, Peng

    southern med univ

  • H

    Huang, Wei

    southern med univ

  • H

    Huang, Shiying

    southern med univ

  • L

    Liao, Huajun

    southern med univ

  • Y

    Yu, Jieying

    southern med univ

  • P

    Pan, Dongmei

    southern med univ

  • W

    Wang, Ming (通讯)

    southern med univ

  • X

    Xiao, Wei (通讯)

    guangdong pharmaceut univ · southern med univ

  • W

    Wen, Xiaomin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417